Neurodon

Crown Point, United States

Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.

$2.9M raised

Oct 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neurodon raised?

Neurodon has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in October 2023.

Who are Neurodon's investors?

Neurodon's investors include Breakthrough T1D, National Institutes of Health.

Where is Neurodon headquartered?

Neurodon is headquartered in Crown Point, United States.

What does Neurodon do?

Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.

What stage is Neurodon at?

Neurodon is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 3, 2023.

MLA

"Neurodon — Funding & Investors." VCBacked, October 3, 2023, https://www.vcbacked.co/company/neurodon. Accessed July 5, 2026.

APA

VCBacked. (2023). Neurodon — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/neurodon

Wikipedia (cite web)

{{cite web |title=Neurodon — Funding & Investors |url=https://www.vcbacked.co/company/neurodon |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 3, 2023.